Newsletter Archive

  1. 07.25.25 -- Understanding FDA's Draft Guidance: Composition Statements Of Ingredients In Labeling In NDAs And ANDAs 7/25/2025
    07/25/25 Pharmaceutical Online Newsletter
  2. 07.24.25 -- Tools For Smarter Antibody Discovery 7/24/2025

    07/24/25 Pharmaceutical Online Newsletter

  3. 07.24.25 -- Preparing For FDA's Expanded Use Of Unannounced Inspections At Foreign Manufacturing Facilities 7/24/2025
    07/24/25 Pharmaceutical Online Newsletter
  4. 07.24.25 -- STREAM Edition: Different Clean Room Regulations For Peptides 7/24/2025

    07/24/25 Pharmaceutical Online Newsletter

  5. 07.22.25 -- Strategic Considerations For Generic GLP-1 Combination Product Development 7/22/2025
    07/22/25 Pharmaceutical Online Newsletter
  6. 07.18.25 -- A Look At Elsa, The FDA's New AI Digital Assistant 7/18/2025
    07/18/25 Pharmaceutical Online Newsletter
  7. 07.17.25 -- Bracing For The Impact Of The Federal Workforce Reduction 7/17/2025

    07/17/25 Pharmaceutical Online Newsletter

  8. 07.17.25 -- STREAM Edition: Reducing Costs, Making Peptide Synthesis Greener 7/17/2025

    07/17/25 Pharmaceutical Online Newsletter

  9. 07.16.25 -- Breaking Barriers: 3D Screen Printing Transforms Drug Formulation 7/16/2025

    07/16/25 Pharmaceutical Online Newsletter

  10. 07.16.25 -- Innovation driving access in advanced therapies 7/16/2025

    07/16/25 Pharmaceutical Online Newsletter